Log In
BCIQ
Print this Print this
 

IPH33

  Manage Alerts
Collapse Summary General Information
Company Innate Pharma S.A.
DescriptionToll-like receptor 3 (TLR3)-targeting mAb
Molecular Target Toll-like receptor 3 (TLR3)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Inflammation (unspecified)
Indication DetailsTreat inflammation
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today